Hungaropharma privatization tender

14 June 2001

Hungaropharmaprivatization tender

APV Rt, Hungary's state privatization company, is to invite tenders for the part sale of the drug wholesaler Hungaropharma Rt, which currently controls a third of the domestic market, reports New Europe.

APV will issue an initial public offering for a quarter plus one vote of Hungaropharma to small and institutional domestics and foreign invstors. The second phase will consist of allowing workers, managers and domestic pharmacists to buy a further 25% minus two votes of the wholesaler. Last year, the firm produced a pretax profit of 328 million forint ($1.1 millon).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight